VEGFA and neuroblastoma: Bocca et al. [23] further evaluated this by investigating the anti-NB activity of GD2-specific CAR T-cells combined with bevacizumab (BEV), a specific mAb against vascular endothelial growth factor (VEGFR), in an orthotopic xenograft model of human NB.